Suicide prevention as a prerequisite for recovery from severe mental illness

International Journal of Psychiatry in Medicine

Volumn 46, Issue 1, 2013, Pages 15-25

  Foster, Tom ^a  

^a Tyrone and Fermanagh Hospital   (United Kingdom)

Author keywords

bipolar disorder; recovery; schizophrenia; suicide prevention

Indexed keywords

CLOZAPINE; LITHIUM; VALPROATE SEMISODIUM;

AGITATION; ARTICLE; BIPOLAR DISORDER; CHILD ABUSE; COGNITIVE THERAPY; DEPRESSION; DRUG MISUSE; ELECTROCONVULSIVE THERAPY; FAMILY THERAPY; FATALITY; HALLUCINATION; HEAD INJURY; HOPELESSNESS; IMPULSIVENESS; MEDICATION COMPLIANCE; MEDLINE; MENTAL HEALTH SERVICE; RESTLESSNESS; RISK ASSESSMENT; RISK FACTOR; RISK MANAGEMENT; SCHIZOPHRENIA; SEX RATIO; SOCIAL ADAPTATION; STANDARDIZED MORTALITY RATIO; SUICIDE; SUICIDE ATTEMPT; VOCATIONAL REHABILITATION;

BIPOLAR DISORDER; HUMANS; RISK ASSESSMENT; SCHIZOPHRENIA; SEVERITY OF ILLNESS INDEX; SUICIDE;

EID: 84889844360     PISSN: 00912174     EISSN: 15413527     Source Type: Journal    
DOI: 10.2190/PM.46.1.b     Document Type: Article

References (54)

1. United States Department of Health & Human Services. National consensus statement on mental health recovery. Rockville, MD: Substance Abuse and Mental Health Services Administration Center for Mental Health Services, 2011. Available at http://hospitals.unm.edu/bh/psr/consensus.shtml
2. Victoria Government Department of Health. Framework for recovery-orientated practice. Melbourne, Australia: Mental Health, Drugs and Regions Division, 2011.
3. Care Services Improvement Partnership, Royal College of Psychiatrists, Social Care Institute for Excellence. A common purpose: Recovery in future mental health services. London, UK: Social Care Institute for Excellence, 2007.
4. Slade M. Personal recovery and mental illness: A guide for mental health professionals. Cambridge, UK: Cambridge University Press, 2009.
5. Arsenault-Lapierre G, Kim C, Turecki G. Psychiatric diagnoses in 3275 suicides: A meta-analysis. BMC Psychiatry 2004;4:37.
6. Stanley B, Jones J. Risk for suicidal behaviour in personality disorders. In Wasserman D, Wassermann C, editors. Oxford textbook of suicidology and suicide prevention (pp. 287-292). Oxford, UK: Oxford University Press, 2009.
7. Foster T, Gillespie K, McClelland R, Patterson C. Risk factors for suicide independent of DSM-III-R Axis I disorder. Case-control psychological autopsy study in Northern Ireland. The British Journal of Psychiatry 1999;75:175-179.
8. Dutta R, Murray RM, Hotopf M, Allardyce J, Jones PB, Boydell J. Reassessing the long-term risk of suicide after a first episode of psychosis. Archives of General Psychiatry 2010;67:1230-1237.
9. Palmer BA, Pankratz VS, Bostwick, JM. The lifetime risk of suicide in schizophrenia. Archives of General Psychiatry 2005;62:247-253.
10. Saha S, Chant D, McGrath J. A systematic review of mortality in schizophrenia. Is the differential mortality gap worsening over time? Archives of General Psychiatry 2007;64:1123-1131.
11. Nordentoft M, Mortensen PB, Pedersen CB. Absolute risk of suicide after first hospital contact in mental disorder. Archives of General Psychiatry 2011;68: 1058-1064.
12. Heila H, Isometsä E, Henriksson MM, Heikkinen ME, Marttunen MJ, Lönnqvist JK. Suicide and schizophrenia: A nationwide psychological autopsy study on age-and sex-specific clinical characteristics of 92 suicide victims with schizophrenia. American Journal of Psychiatry 1997;154:1235-1242.
13. Heila H, Isometsä ET, Henriksson MM, Heikkinen ME, Marttunen MJ, Lönnqvist JK. Suicide victims with schizophrenia in different treatment phases and adequacy of antipsychotic medication. The Journal of Clinical Psychiatry 1999;60:200-208.
14. Ward A, Ishak K, Proskorovsky I, Caro J. Compliance with refilling prescriptions for atypical antipsychotic agents and its association with the risks for hospitalization, suicide, and death in patients with schizophrenia in Quebec and Saskatchewan: A retrospective database study. Clinical Therapeutics 2006;28:1912-1921.
15. Hawton K, Sutton L, Haw C, Sinclair, J, Deeks JJ. Schizophrenia and suicide: Systematic review of risk factors. The British Journal of Psychiatry 2005;187:9-20.
16. Hor K, Taylor M. Suicide and schizophrenia: A systematic review of rates and risk factors. Journal of Psychopharmacology 2010;24(Suppl 4):81-90.
17. Kasckow J, Liu N, Haas GL, Phillips MR. Case-control study of the relationship of depressive symptoms to suicide in a community-based sample of individuals with schizophrenia in China. Schizophrenia Research 2010;122:226-231.
18. Tiihonen J, Wahlbeck K, Lönnqvist J, Klaukka T, Ioannidis JPA, Volavka J, Haukka J. Effectiveness of antipsychotic treatments in a nationwide cohort of patients in community care after first hospitalisation due to schizophrenia and schizoaffective disorder: Observational follow-up study. British Medical Journal 2006;333:224-227.
19. Hennen J, Baldessarini RJ. Suicidal risk during treatment with clozapine: A metaanalysis. Schizophrenia Research 2005;73:139-145.
20. Farooq S, Taylor M. Clozapine: Dangerous orphan or neglected friend? The British Journal of Psychiatry 2011;198:247-249.
21. Hunt IM, Kapur N, Windfuhr K, Robinson J, Bickley H, Flynn S, Parsons R, Burns J, Shaw J, Appleby L. Suicide in schizophrenia: Findings from a national clinical survey. Journal of Psychiatric Practice 2006;12:139-147.
22. Roy A, Pompili M. Management of schizophrenia with suicide risk. Psychiatric Clinics of North America 2009;32:863-883.
23. Ösby U, Brandt L, Correia N, Ekbom A, Sparén P. Excess mortality in bipolar and unipolar disorder in Sweden. Archives of General Psychiatry 2001;58: 844-850.
24. Hawton K, Sutton L, Haw C, Sinclair J, Harriss L. Suicide and attempted suicide in bipolar disorder: A systematic review of risk factors. Journal of Clinical Psychiatry 2005;6:693-704.
25. Dutta R, Boydell J, Kennedy N, Van Os J, Fearon P, Murray RM. Suicide and other causes of mortality in bipolar disorder: A longitudinal study. Psychological Medicine 2007;37:839-847.
26. Isometsä E, Henriksson MM, Aro HM, Lönnqvist JK. Suicide in bipolar disorder in Finland. American Journal of Psychiatry 1994;15:1020-1024.
27. Baldessarini RJ, Tondo L, Davis P, Pompili M, Goodwin FK, Hennen J. Decreased risk of suicides and attempts during long-term lithium treatment: A meta-analytic review. Bipolar Disorders 2006;8:625-639.
28. Goodwin FK, Fireman B, Simon GE, Hunkeler EM, Lee J, Revicki D. Suicide risk in bipolar disorder during treatment with lithium and divalproex. The Journal of the American Medical Association 2003;290:1467-1473.
29. Oquendo MA, Galfalvy HC, Currier D, Grunebaum MF, Sher L, Sullivan GM, Burke AK, Harkavy-Friedman J, Sublette ME, Parsey RV, Mann JJ. Treatment of suicide attempters with bipolar disorder: A randomized clinical trial comparing lithium and valproate in the prevention of suicidal behaviour. American Journal of Psychiatry 2011;168:1050-1056.
30. Perlis RH. Hard outcomes: Clinical trials to reduce suicide. American Journal of Psychiatry 2011;168:1009-1011.
31. Pompili M, Rihmer Z, Innamorati M, Lester D, Girardi P, Tatarelli R. Assessment and treatment of suicide risk in bipolar disorders. Expert Review of Neurotherapeutics 2009;9:109-136.
32. Gray SM, Otto MW. Psychosocial approaches to suicide prevention: Applications to patients with bipolar disorder. The Journal of Clinical Psychiatry 2001;62(Suppl 25):56-64.
33. Royal College of Psychiatrists. Self-harm, suicide and risk: Helping people who selfharm (College Report CR158). London, UK: Royal College of Psychiatrists, 2009.
34. Kendall T, Taylor C, Bhatti H, Chan M, Kapur N. On behalf of the Guideline Development Group. Longer term management of self harm: Summary of NICE guidance. British Medical Journal 2011;343:d7073.
35. Appleby L. Suicide prevention: The evidence on safer clinical care is now good and should be adopted internationally. International Psychiatry 2012;9:27-29.
36. Mehlum L. Treatment of suicide attempts and suicidal patients in psychiatric care. In Wasserman D, Wasserman C, editors. Oxford textbook of suicidology and suicide prevention (pp. 471-476). Oxford, UK: Oxford University Press, 2009.
37. Qin P, Nordentoft M. Suicide risk in relation to psychiatric hospitalization. Archives of General Psychiatry 2005;62:427-432.
38. Eagles JM, Carson DP, Begg A, Naji SA. Suicide prevention: A study of patients' views. The British Journal of Psychiatry 2003;182:261-265.
39. Pompili M, Mancinelli I, Tatarelli R. Stigma as a cause of suicide. The British Journal of Psychiatry 2003;183:173-174.
40. Mann JJ, Apter A, Bertolote J, Beautrais A, Currier D, Haas A, Hegerl U, Lönnqvist J, Malone K, Marusic A, Mehlum L, Patton G, Phillips M, Rutz W, Rihmer Z, Schmidtke A, Shaffer D, Silverman M, Takahashi Y, Varnik A, Wasserman D, Yip P, Hendin H. Suicide prevention strategies: A systematic review. The Journal of the American Medical Association 2005;294:2064-2074.
41. Lewiecki EM, Miller SA. Suicide, guns, and public policy. American Journal of Public Health 2013;103:27-31.
42. Appleby L. Prevention of suicide in psychiatric patients. In Hawton K, van Heeringen K, editors. The international handbook of suicide and attempted suicide (pp. 617-630). Chichester, UK: Wiley, 2000.
43. Royal College of Psychiatrists. Report of the National Audit of Schizophrenia (NAS). London, UK: Healthcare Quality Improvement Partnership, 2012.
44. Wasserman D, Rihmer Z, Rujescu D, Sarchiapone M, Sokolowski M, Titelman D, Zalsman G, Zemishlany Z, Carli, V. The European Psychiatric Association (EPA) guidance on suicide treatment and prevention. European Psychiatry 2012;27:129-141.
45. While D, Bickley H, Roscoe A, Windfuhr K, Rahman S, Shaw J, Appleby L, Kapur N. Implementation of mental health service recommendations in England and Wales and suicide rates, 1997-2006: A cross-sectional and before-and-after observational study. The Lancet 2012;379:1005-1012.
46. Hunt IM, Kapur N, Webb R, Robinson J, Burns J, Turnbull P, Shaw J, Appleby L. Suicide in current psychiatric in-patients: A case-control study. Psychological Medicine 2007;37:831-837.
47. Foster T. Adverse life events proximal to adult suicide: A synthesis of findings from psychological autopsy studies. Archives of Suicide Research 2011;15:1-15.
48. Pirkola S, Sund R, Salias E, Wahlbeck K. Community mental-health services and suicide rate in Finland: A nationwide small-area analysis. The Lancet 2009;373: 147-153.
49. Huguelet P, Mohr S, Jung V, Gillieron C, Brandt P-Y, Borras L. Effect of religion on suicide attempts in outpatients with schizophrenia or schizoaffective disorders compared with inpatients with non-psychotic disorders. European Psychiatry 2007; 22:188-194.
50. Dervic K, Carballo JJ, Baca-Garcia E, Galfalvy HC, Mann JJ, Brent DA, Oquendo MA. Moral or religious objections to suicide may protect against suicidal behaviour in bipolar disorder. The Journal of Clinical Psychiatry 2011;72:1390-1396.
51. Kendler KS, Gardner CO, Prescott CA. Religion, psychopathology, and substance use and abuse: A multimeasure, genetic-epidemiologic study. American Journal of Psychiatry 1997;154:322-329.
52. Kendler KS, Liu XQ, Gardner CO, McCullough ME, Larson D, Prescott CA. Dimensions of religiosity and their relationship to lifetime psychiatric and substance use disorders. American Journal of Psychiatry 2003;160:496-503.
53. Rihmer Z, Rutz W. Treatment of attempted suicide and suicidal patients in primary care. In Wasserman D, Wassermann C, editors. Oxford textbook of suicidology and suicide prevention (pp. 463-470). Oxford, UK: Oxford University Press, 2009.
54. McDowell AK, Lineberry TW, Bostwick JM. Practical suicide-risk management for the busy primary care physician. Mayo Clinic Proceedings 2011;86(8):792-800.